OPEN ACCESS JOURNALS

           

home

about us

journals

search

African Journal of Pharmacy and Pharmacology

     

   AJPP Home

   About AJPP

   Submit Manuscripts

   Instructions for Authors

   Editors

   Call For Paper

   Archive

   Faculty 1000

   Conferences

   Associations

 Afr. J. Pharm. Pharmacol.

 

Vol. 6  No. 1
 

Viewing options:


 •Abstract
 •Reprint (PDF) (96K)

Search Pubmed for articles by:

 

Bing D

Ling Q

 

 

 

Other links:
PubMed Citation
Related articles in PubMed

Other Journals

African Journal of Agricultural Research

African Journal  of Environmental Science & Technology

Biotechnology & Molecular Biology Reviews

African Journal of Biochemistry Research

African Journal of Microbiology Research

African Journal of Pure & Applied Chemistry

African Journal of Food Science

Journal of Cell & Animal Biology

African Journal of Pharmacy & Pharmacology

African Journal of Biotechnology

Journal of Medicinal Plant Research

International Journal of Physical Sciences

Scientific Research and Essays

 

African Journal of Pharmacy and Pharmacology Vol. 6(1), pp. 36- 42, 8 January, 2012

DOI: 10.5897/AJPP11.452

ISSN 1996-0816 ©2012 Academic Journals

 

 

Full Length Research Paper

 

A meta-analysis of the efficacy and safety of arotinolol in the treatment of Chinese patients with essential hypertension

 

Du Bing1#Cui Wen-peng2#Xu Guo-liang1, Sun Guo-qiang1, Wu Guo-dong1, Qu Rui1,

Lin Shu-mei1, Liu Yun-yang1, Qin Ling1*

 

1Department of Cardiology, the second part of First Hospital, Jilin University, Changchun, China.

2Department of Nephrology, Second Hospital, Jilin University, Changchun, China.

 

*Corresponding author. E-mail: qinling1958@yahoo.com.cn. Tel: +86 15843073203; Fax: +86 0431 84841049.

 

#These authors contributed equally to this work and should be considered co-first authors.

 

Accepted 8 September, 2011

 

 Abstract

 

Arotinolol had been used for treatment of essential hypertension. We conducted a meta-analysis to compare the efficacy and safety of arotinolol with other antihypertensive drugs in treating essential hypertension. Medical databases and review articles were screened with prespecified criteria for randomized controlled trials that reported the effects of and adverse reactions to arotinolol and other antihypertensive drugs in treating essential hypertension. Literature identified meta-analysed using RevMan4.2. Methodology quality of the selected studies was conducted using a Jadad scale. The results were that a total of 176 articles had been found of which 6 were finally included for meta-analysis. The meta-analysis compared the efficacy and safety of arotinolol with other common antihypertensive drugs, including enalapril, felodipine, imidapril, cilinidipine, metroprolol and atenolol. Results indicated that there were no evidence for differences in safety and efficacy. Homogeneity test, χ2 = 4.41, df = 7, P = 0.73 (efficacy); χ2 = 2.96, df = 4, P = 0.56 (safety); combined test, Z = 0.64 (P = 0.52), OR = 1.17, 95% confidence interval (CI) (0.72, 1.85) (efficacy); Z = 1.75 (P = 0.08), OR = 0.60, 95% CI (0.34, 1.06) (safety). There was no significant difference in efficacy and safety between arotinolol and other common antihypertensive drugs used for treating essential hypertension.

 

Key words: Meta-analysis, arotinolol, essential hypertension, efficacy, safety.

 

 

 

 

___________________________________________________________________________________________________________

Advertise on AJPP | Terms of Use | Privacy Policy | Help

© Academic Journals 2002 - 2012